Media & Events

Keep up-to-date on the latest media coverage and events for IceCure Medical.

Our Press Releases >

Filter by:

News

IceCure Medical Delivers Conference Call Investor Update Sept 2019

IceCure CEO, Eyal Shamir and CFO, Ronen Tsimerman update on IceCure progress in investor conference call, Sept 2019. Listen to the full conference call here.

Read More >

News

IceCure Medical Forges Landmark Strategic Deal with Global Medical Company, Terumo Corporation

The exclusive distribution agreement, supported by Terumo’s strong commitment, will accelerate commercialization of its ProSense™ cryoablation system to treat breast cancer tumors in Japan and Singapore, pending regulatory approval. Read more

Read More >

News

IceCure Receives Israeli AMAR Approval for Use of its Freezing Technology in Specific Indications, Following an Earlier General Approval

The AMAR approval allows for freezing of benign and malignant tumors including breast, lungs, bones, liver, lymphatic tissue, lymph nodes and endocrine glands. This achievement comes hot on the back of the company receiving a Class 3 CPT code from

Read More >

News

ICECURE PLATINUM SPONSOR OF THE 20TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY OF CRYOSURGERY, SEPT 4-5, 2019.

Demonstrating our commitment to advance the treatment of cancer using cryosurgery, we are proud to be the Platinum sponsor of the 20th World Congress of the International Society of Cryosurgery: Sept 4-5, 2019, Haifa, Israel. With talks from top experts

Read More >

News

IceCure Medical Announces New Category III CPT Code for Breast Cryoablation Therapy, Issued by the American Medical Association

New Category III CPT Code expected to support further adoption of minimally invasive cryoablation treatments for breast cancer. Learn more.

Read More >

IceCure Medical Announces New Category III CPT Code for Breast Cryoablation Therapy, Issued by the American Medical Association